{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:30:47Z","timestamp":1793302247043,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T00:00:00Z","timestamp":1454889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca (IT)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00198-016-3501-2","type":"journal-article","created":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T08:50:27Z","timestamp":1454921427000},"page":"2355-2365","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-\u03b1"],"prefix":"10.1007","volume":"27","author":[{"given":"G.","family":"Brunetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Papadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tummolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Fischetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Nicastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Piacente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Oranger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Gigante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Colucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ciccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Grano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Delvecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. F.","family":"Faienza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,8]]},"reference":[{"key":"3501_CR1","first-page":"2336","volume-title":"Nelson textbook of pediatrics","author":"JC Marini","year":"2001","unstructured":"Marini JC (2001) Osteogenesis imperfecta. In: Behrman RE, Kliegman RM, Jensen HB (eds) Nelson textbook of pediatrics, 17th edn. Saunders, Philadelphia, pp 2336\u20132338","edition":"17"},{"key":"3501_CR2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrendo.2011.81","volume":"7","author":"A Forlino","year":"2011","unstructured":"Forlino A, Cabral WA, Barnes AM, Marini JC (2011) New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol 7:540\u2013557","journal-title":"Nat Rev Endocrinol"},{"key":"3501_CR3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11154-008-9074-4","volume":"9","author":"MS Cheung","year":"2008","unstructured":"Cheung MS, Glorieux FH (2008) Osteogenesis imperfecta: update on presentation and management. Rev Endocr Metab Disord 9:153\u2013160","journal-title":"Rev Endocr Metab Disord"},{"key":"3501_CR4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ajmg.c.31334","volume":"160C","author":"M Rohrbach","year":"2012","unstructured":"Rohrbach M, Giunta C (2012) Recessive osteogenesis imperfecta: clinical, radiological, and molecular findings. Am J Med Genet C: Semin Med Genet 160C:175\u2013189","journal-title":"Am J Med Genet C: Semin Med Genet"},{"key":"3501_CR5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S8756-3282(00)00269-6","volume":"26","author":"F Rauch","year":"2000","unstructured":"Rauch F, Travers R, Parfitt AM, Glorieux FH (2000) Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone 26:581\u2013589","journal-title":"Bone"},{"key":"3501_CR6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1203\/00006450-198303000-00007","volume":"17","author":"R Baron","year":"1983","unstructured":"Baron R, Gertner JM, Lang R, Vignery A (1983) Increased bone turnover with decreased bone formation by osteoblasts in children with osteogenesis imperfecta tarda. Pediatr Res 17:204\u2013207","journal-title":"Pediatr Res"},{"key":"3501_CR7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40200-014-0109-y","volume":"13","author":"G Eghbali-Fatourechi","year":"2014","unstructured":"Eghbali-Fatourechi G (2014) Bisphosphonate therapy in pediatric patients. J Diabetes Metab Disord 13:109","journal-title":"J Diabetes Metab Disord"},{"key":"3501_CR8","doi-asserted-by":"publisher","first-page":"CD005088","DOI":"10.1002\/14651858.CD005088.pub3","volume":"7","author":"K Dwan","year":"2014","unstructured":"Dwan K, Phillipi CA, Steiner RD, Basel D (2014) Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev 7:CD005088. doi:\n10.1002\/14651858.CD005088.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"3501_CR9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1359\/JBMR.051207","volume":"21","author":"C Land","year":"2006","unstructured":"Land C, Rauch F, Glorieux FH (2006) Cyclical intravenous pamidronate treatment affects metaphyseal modeling in growing patients with osteogenesis imperfecta. J Bone Miner Res 21:374\u2013379","journal-title":"J Bone Miner Res"},{"key":"3501_CR10","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1038\/nm.3074","volume":"19","author":"R Baron","year":"2013","unstructured":"Baron R, Kneissel M (2013) WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 19:1791\u20131792","journal-title":"Nat Med"},{"key":"3501_CR11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nature756","volume":"417","author":"B Mao","year":"2002","unstructured":"Mao B, Wu W, Davidson G, Marhold J, Li M, Mechler BM, Delius H, Hoppe D, Stannek P, Walter C, Glinka A, Niehrs C (2002) Kremen proteins are Dickkopf receptors that regulate Wnt\/beta-catenin signalling. Nature 417:664\u2013667","journal-title":"Nature"},{"key":"3501_CR12","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","volume":"280","author":"X Li","year":"2005","unstructured":"Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, Harris SE, Wu D (2005) Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling. J Biol Chem 280:19883\u201319887","journal-title":"J Biol Chem"},{"key":"3501_CR13","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1359\/jbmr.060311","volume":"21","author":"F Morvan","year":"2006","unstructured":"Morvan F, Boulukos K, Cl\u00e9ment-Lacroix P, Roman Roman S, Suc-Royer I, Vayssi\u00e8re B, Ammann P, Martin P, Pinho S, Pognonec P, Mollat P, Niehrs C, Baron R, Rawadi G (2006) Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res 21:934\u2013945","journal-title":"J Bone Miner Res"},{"key":"3501_CR14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1182\/blood-2008-01-132134","volume":"112","author":"YW Qiang","year":"2008","unstructured":"Qiang YW, Chen Y, Stephens O, Brown N, Chen B, Epstein J, Barlogie B, Shaughnessy JD Jr (2008) Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma. Blood 112:196\u2013207","journal-title":"Blood"},{"key":"3501_CR15","doi-asserted-by":"crossref","first-page":"R164","DOI":"10.1186\/ar3123","volume":"12","author":"N Dalbeth","year":"2010","unstructured":"Dalbeth N, Pool B, Smith T, Callon KE, Lobo M, Taylor WJ, Jones PB, Cornish J, McQueen FM (2010) Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion. Arthritis Res Ther 12:R164","journal-title":"Arthritis Res Ther"},{"key":"3501_CR16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","volume":"13","author":"D Diarra","year":"2007","unstructured":"Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffmann M, Scheinecker C, van der Heide D, Landewe R, Lacey D, Richards WG, Schett G (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13:156\u2013163","journal-title":"Nat Med"},{"key":"3501_CR17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","volume":"15","author":"DO Sillence","year":"1979","unstructured":"Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 15:101\u2013116","journal-title":"J Med Genet"},{"key":"3501_CR18","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1359\/JBMR.041232","volume":"20","author":"D Gatti","year":"2005","unstructured":"Gatti D, Antoniazzi F, Prizzi R, Braga V, Rossini M, Tat\u00f2 L, Viapiana O, Adami S (2005) Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study. J Bone Miner Res 20:758\u2013763","journal-title":"J Bone Miner Res"},{"key":"3501_CR19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1542\/peds.109.1.45","volume":"109","author":"CL Ogden","year":"2002","unstructured":"Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL (2002) Centers for disease control and prevention 2000 growth charts for the united states: improvements to the 1977 national center for health statistics version. Pediatrics 109:45\u201360","journal-title":"Pediatrics"},{"key":"3501_CR20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0022-1759(00)00238-6","volume":"243","author":"DA Vignali","year":"2000","unstructured":"Vignali DA (2000) Multiplexed particle-based flow cytometric assays. J Immunol Methods 243:243\u2013255","journal-title":"J Immunol Methods"},{"key":"3501_CR21","doi-asserted-by":"crossref","first-page":"480","DOI":"10.7150\/ijms.4583","volume":"9","author":"G Mori","year":"2012","unstructured":"Mori G, Ballini A, Carbone C, Oranger A, Brunetti G, Di Benedetto A, Rapone B, Cantore S, Di Comite M, Colucci S, Grano M, Grassi FR (2012) Osteogenic differentiation of dental follicle stem cells. Int J Med Sci 9:480\u2013487","journal-title":"Int J Med Sci"},{"key":"3501_CR22","doi-asserted-by":"crossref","first-page":"E546","DOI":"10.1152\/ajpendo.00535.2012","volume":"304","author":"G Brunetti","year":"2013","unstructured":"Brunetti G, Faienza MF, Piacente L, Ventura A, Oranger A, Carbone C, Benedetto AD, Colaianni G, Gigante M, Mori G, Gesualdo L, Colucci S, Cavallo L, Grano M (2013) High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment. Am J Physiol Endocrinol Metab 304:E546\u2013554","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3501_CR23","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1074\/jbc.M111.253187","volume":"287","author":"WG Jang","year":"2012","unstructured":"Jang WG, Kim EJ, Kim DK, Ryoo HM, Lee KB, Kim SH, Choi HS, Koh JT (2012) BMP2 protein regulates osteocalcin expression via Runx2-mediated Atf6 gene transcription. J Biol Chem 287:905\u2013915","journal-title":"J Biol Chem"},{"key":"3501_CR24","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.bone.2011.11.028","volume":"50","author":"D Gatti","year":"2012","unstructured":"Gatti D, Viapiana O, Adami S, Idolazzi L, Fracassi E, Rossini M (2012) Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. Bone 50:739\u2013742","journal-title":"Bone"},{"key":"3501_CR25","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bone.2004.02.023","volume":"34","author":"V Braga","year":"2004","unstructured":"Braga V, Gatti D, Rossini M, Colapietro F, Battaglia E, Viapiana O, Adami S (2004) Bone turnover markers in patients with osteogenesis imperfecta. Bone 34:1013\u20131016","journal-title":"Bone"},{"key":"3501_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13481","author":"P Giordano","year":"2015","unstructured":"Giordano P, Brunetti G, Lassandro G, Notarangelo LD, Luciani M, Mura RM, Lazzareschi I, Santagostino E, Piacente L, Ventura A, Cavallo L, Grano M, Faienza MF (2015) High serum sclerostin levels in children with haemophilia A. Br J Haematol. doi:\n10.1111\/bjh.13481","journal-title":"Br J Haematol"},{"key":"3501_CR27","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/sj.bjc.6604069","volume":"97","author":"N Lee","year":"2007","unstructured":"Lee N, Smolarz AJ, Olson S, David O, Reiser J, Kutner R, Daw NC, Prockop DJ, Horwitz EM, Gregory CA (2007) A potential role for Dkk-1 in the pathogenesis of osteosarcoma predicts novel diagnostic and treatment strategies. Br J Cancer 97:1552\u20131559","journal-title":"Br J Cancer"},{"key":"3501_CR28","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/CIRCRESAHA.107.172718","volume":"103","author":"A Aicher","year":"2008","unstructured":"Aicher A, Kollet O, Heeschen C, Liebner S, Urbich C, Ihling C, Orlandi A, Lapidot T, Zeiher AM, Dimmeler S (2008) The Wnt antagonist Dickkopf-1 mobilizes vasculogenic progenitor cells via activation of the bone marrow endosteal stem cell niche. Circ Res 103:796\u2013803","journal-title":"Circ Res"},{"key":"3501_CR29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1476-4598-6-71","volume":"6","author":"K Fujita","year":"2007","unstructured":"Fujita K, Janz S (2007) Attenuation of WNT signaling by DKK-1 and \u22122 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF. Mol Cancer 6:71","journal-title":"Mol Cancer"},{"key":"3501_CR30","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1365-2141.2006.06356.x","volume":"135","author":"E Terpos","year":"2006","unstructured":"Terpos E, Heath DJ, Rahemtulla A, Zervas K, Chantry A, Anagnostopoulos A, Pouli A, Katodritou E, Verrou E, Vervessou EC, Dimopoulos MA, Croucher PI (2006) Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma. Br J Haematol 135:688\u2013692","journal-title":"Br J Haematol"},{"key":"3501_CR31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00223-015-9969-5","volume":"96","author":"M Rossini","year":"2015","unstructured":"Rossini M, Viapiana O, Zanotti R, Tripi G, Perbellini O, Idolazzi L, Bonifacio M, Adami S, Gatti D (2015) Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis. Calcif Tissue Int 96:410\u2013416","journal-title":"Calcif Tissue Int"},{"key":"3501_CR32","first-page":"77","volume":"33","author":"M Rossini","year":"2015","unstructured":"Rossini M, Viapiana O, Adami S, Fracassi E, Idolazzi L, Dartizio C, Povino MR, Orsolini G, Gatti D (2015) In patients with rheumatoid arthritis, DKK1 serum levels are correlated with parathyroid hormone, bone erosions and BMD. Clin Exp Rheumatol 33:77\u201383","journal-title":"Clin Exp Rheumatol"},{"key":"3501_CR33","first-page":"77","volume":"12","author":"L Zeitlin","year":"2003","unstructured":"Zeitlin L, Fassier F, Glorieux FH (2003) Modern approach to children with osteogenesis imperfecta. J Pediatr Orthop B 12:77\u201387","journal-title":"J Pediatr Orthop B"},{"key":"3501_CR34","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1210\/endo.143.5.8807","volume":"143","author":"I Kalajzic","year":"2002","unstructured":"Kalajzic I, Terzic J, Rumboldt Z, Mack K, Naprta A, Ledgard F, Gronowicz G, Clark SH, Rowe DW (2002) Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse. Endocrinology 143:1594\u20131601","journal-title":"Endocrinology"},{"key":"3501_CR35","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/jcb.21337","volume":"102","author":"H Zhang","year":"2007","unstructured":"Zhang H, Doty SB, Hughes C, Dempster D, Camacho NP (2007) Increased resorptive activity and accompanying morphological alterations in osteoclasts derived from the oim\/oim mouse model of osteogenesis imperfecta. J Cell Biochem 102:1011\u20131020","journal-title":"J Cell Biochem"},{"key":"3501_CR36","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1359\/jbmr.080804","volume":"23","author":"TE Uveges","year":"2008","unstructured":"Uveges TE, Collin-Osdoby P, Cabral WA, Ledgard F, Goldberg L, Bergwitz C, Forlino A, Osdoby P, Gronowicz GA, Marini JC (2008) Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors. J Bone Miner Res 23:1983\u20131994","journal-title":"J Bone Miner Res"},{"key":"3501_CR37","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.2353\/ajpath.2010.090704","volume":"176","author":"H Li","year":"2010","unstructured":"Li H, Jiang X, Delaney J, Franceschetti T, Bilic-Curcic I, Kalinovsky J, Lorenzo JA, Grcevic D, Rowe DW, Kalajzic I (2010) Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine. Am J Pathol 176:2405\u20132413","journal-title":"Am J Pathol"},{"key":"3501_CR38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1203\/PDR.0b013e31815efd63","volume":"63","author":"P D\u2019Eufemia","year":"2008","unstructured":"D\u2019Eufemia P, Finocchiaro R, Celli M, Zambrano A, Tetti M, Villani C, Persiani P, Mari E, Zicari A (2008) High levels of serum prostaglandin E2 in children with osteogenesis imperfecta are reduced by neridronate treatment. Pediatr Res 63:203\u2013206","journal-title":"Pediatr Res"},{"key":"3501_CR39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s002230010045","volume":"69","author":"NP Camacho","year":"2001","unstructured":"Camacho NP, Raggio CL, Doty SB, Root L, Zraick V, Ilg WA, Toledano TR, Boskey AL (2001) A controlled study of the effects of alendronate in a growing mouse model of osteogenesis imperfecta. Calcif Tissue Int 69:94\u2013101","journal-title":"Calcif Tissue Int"},{"key":"3501_CR40","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S8756-3282(02)00974-2","volume":"32","author":"KD Evans","year":"2003","unstructured":"Evans KD, Lau ST, Oberbauer AM, Martin RB (2003) Alendronate affects long bone length and growth plate morphology in the oim mouse model for Osteogenesis Imperfecta. Bone 32:268\u2013274","journal-title":"Bone"},{"key":"3501_CR41","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1203\/00006450-200211000-00010","volume":"52","author":"EA McCarthy","year":"2002","unstructured":"McCarthy EA, Raggio CL, Hossack MD, Miller EA, Jain S, Boskey AL, Camacho NP (2002) Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model. Pediatr Res 52:660\u2013670","journal-title":"Pediatr Res"},{"key":"3501_CR42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/jor.20469","volume":"26","author":"D Delos","year":"2008","unstructured":"Delos D, Yang X, Ricciardi BF, Myers ER, Bostrom MP, Camacho NP (2008) The effects of RANKL inhibition on fracture healing and bone strength in a mouse model of osteogenesis imperfecta. J Orthop Res 26:153\u2013164","journal-title":"J Orthop Res"},{"key":"3501_CR43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/03008200903108472","volume":"51","author":"R Bargman","year":"2010","unstructured":"Bargman R, Huang A, Boskey A, Raggio C, Pleshko N (2010) RANKL inhibition improves bone properties in a mouse model of osteogenesis imperfecta. Connect Tissue Res 51:123\u2013131","journal-title":"Connect Tissue Res"},{"key":"3501_CR44","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/pr.2012.118","volume":"72","author":"R Bargman","year":"2012","unstructured":"Bargman R, Posham R, Boskey A, Carter E, DiCarlo E, Verdelis K, Raggio C, Pleshko N (2012) High- and low-dose OPG-Fc cause osteopetrosis-like changes in infant mice. Pediatr Res 72:495\u2013501","journal-title":"Pediatr Res"},{"key":"3501_CR45","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00198-011-1742-7","volume":"23","author":"R Bargman","year":"2012","unstructured":"Bargman R, Posham R, Boskey AL, DiCarlo E, Raggio C, Pleshko N (2012) Comparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta. Osteoporos Int 23:1141\u20131150","journal-title":"Osteoporos Int"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-016-3501-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3501-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3501-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3501-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:15:31Z","timestamp":1558610131000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-016-3501-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,8]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["3501"],"URL":"https:\/\/doi.org\/10.1007\/s00198-016-3501-2","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,8]]}}}